abstract Timely and effective antithrombotic therapy is critical to improving outcome,
including survival, in patients with acute coronary syndrome (ACS). Achieving effective …

Antithrombotic therapy represents the cornerstone of the pharmacological treatment in
patients with acute coronary syndrome (ACS). The optimal combination and duration of …

Antithrombotic agents are an integral component of the medical regimens and interventional
strategies currently recommended to reduce thrombotic complications in patients with acute …

Background Several new antithrombotic therapies have emerged for the treatment of acute
coronary syndrome (ACS). We sought to assess contemporary patterns of antithrombotic …

In patients undergoing percutaneous coronary intervention (PCI) for acute coronary
syndrome (ACS), both periprocedural acute myocardial infarction and bleeding …

Plaque erosions and ruptures are the histopathological hallmarks of arterial thrombus
formation in the coronary arteries. The clinical condition associated with this process is …

Antithrombotic Therapy after Acute Coronary Syndromes Antithrombotic therapy is a central
component of treatment after acute coronary syndromes. The focus is on antiplatelet therapy …

Aims Patients with acute coronary syndromes (ACSs) who are managed without coronary
revascularization represent a mixed and understudied population that seems to receive …

Balance between thrombosis and bleeding is now well recognized in patients treated for
acute coronary syndrome, with impact on short-and long-term prognosis, including survival …

In this review, we report a contemporary appraisal of the available evidence focusing on
adjunctive antithrombotic therapy and technical aspects of percutaneous coronary …